Healthcare Services

Integration Of Remote Programming Capabilities In Miniaturized Rechargeable Systems For Personalized Therapy Management Is Playing A Role In Shaping The Deep Brain Stimulation In Parkinson`s Disease Market

May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Deep Brain Stimulation In Parkinson`s Disease Market Over The 2026–2030 Period?

The deep brain stimulation in parkinson’s disease market has experienced robust expansion in recent years. Projections indicate its value will rise from $3.27 billion in 2025 to $3.49 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. Historically, this growth has been driven by factors such as the rising incidence of Parkinson’s disease, greater uptake of DBS devices, enhanced public understanding of sophisticated neuromodulation treatments, the development of neurosurgical facilities, and increased expenditure on healthcare.

The deep brain stimulation in Parkinson’s disease market is projected to experience robust expansion over the coming years. This market is anticipated to reach $4.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the projected timeframe include an increasing need for customized neuromodulation treatments, greater financial commitments to research and clinical studies, improved availability of tele-neurology provisions, broader reimbursement scope, and a surge in the acceptance of MRI-safe and rechargeable devices. Key trends expected within the forecast period encompass technological progress in closed-loop and directional stimulation, novel developments in rechargeable and extended-life implantable pulse generators (IPGs), progress in AI-supported DBS programming, ongoing research and development into less invasive surgical methods, and enhancements in remote patient monitoring and telemedicine functionalities.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30568&type=smp

What Key Factors Are Affecting The Deep Brain Stimulation In Parkinson`s Disease Market Demand?

The growing population of individuals suffering from Parkinson’s disease is expected to boost the expansion of the deep brain stimulation in Parkinson’s disease market moving forward. Parkinson’s disease is characterized as a progressive neurological condition that impairs movement, leading to symptoms like tremors, rigidity, slowed motion, and poor balance, primarily due to the deterioration of dopamine-producing neurons in the brain. The increase in Parkinson’s disease diagnoses is largely attributed to the world’s aging demographic, as the likelihood of developing the condition significantly rises with age. Deep brain stimulation provides relief for Parkinson’s patients by delivering focused electrical pulses to specific brain regions, thereby lessening motor symptoms, enhancing overall quality of life, and reducing reliance on prolonged medication. For instance, data from the Parkinson’s Foundation indicates that in 2025, approximately 1.1 million people in the United States are living with Parkinson’s disease, a number anticipated to reach 1.2 million by 2030, with nearly 90,000 new diagnoses each year and more than 10 million people affected worldwide. Consequently, the increasing prevalence of Parkinson’s disease patients is a key factor driving the growth of the deep brain stimulation in Parkinson’s disease market. The escalating healthcare expenditure is projected to stimulate the growth of the deep brain stimulation in Parkinson’s disease market in the coming years. Healthcare expenditure encompasses the total financial investments allocated to health services by governments, businesses, and individuals, covering medical treatments, hospital care, pharmaceuticals, and public health initiatives. The increasing necessity for healthcare spending is driven by the rising incidence of chronic diseases, which often demand extensive and costly ongoing treatments. Elevated healthcare expenditure facilitates deep brain stimulation for Parkinson’s disease through funding for advanced surgical interventions, necessary equipment, and subsequent follow-up care. This ultimately improves patient outcomes by expanding access to this effective therapy, which helps to alleviate motor symptoms and boost the overall quality of life. As an illustration, in May 2024, the Office for National Statistics reported that total healthcare expenditure experienced a 5.6% increase in nominal terms in 2023, marking an increase of 0.9% growth compared to 2022. Therefore, the expanding healthcare expenditure is a significant impetus behind the growth of the deep brain stimulation in Parkinson’s disease market.

What Are The Main Segments Within The Deep Brain Stimulation In Parkinson`s Disease Market Segment Structure?

The deep brain stimulation in parkinson`s disease market covered in this report is segmented –

1) By Product Type: Implantable Pulse Generators (IPGs), Electrodes And Leads, External Programmers, Accessories And Consumables

2) By Technology: Conventional Deep Brain Stimulation (DBS) Systems, Closed Loop Deep Brain Stimulation (DBS) Systems, Wireless Deep Brain Stimulation (DBS) Systems

3) By Service Type: Pre-Surgical Evaluation Services, Surgical Implantation Services, Device Programming Services, Patient Monitoring Services, Maintenance And Follow-Up Services, Rehabilitation Support Services, Tele-Neurology Support Services, Training And Education Services

4) By Application: Tremor Management, Rigidity And Stiffness Management, Bradykinesia (Slow Movement) Management, Dyskinesia Management

5) By End-Users: Hospitals, Ambulatory Surgical Centres, Neurology Clinics

Subsegments:

1) By Implantable Pulse Generators (IPGs): Rechargeable Implantable Pulse Generators, Non-Rechargeable Implantable Pulse Generators, Directional Implantable Pulse Generators

2) By Electrodes And Leads: Cylindrical Electrodes, Directional Electrodes, Stimulation Leads

3) By External Programmers: Handheld External Programmers, Desktop External Programmers, Wireless External Programmers

4) By Accessories And Consumables: Extension Cables, Battery Chargers, Surgical Tool Kits

What Trends Are Influencing Changes In The Deep Brain Stimulation In Parkinson`s Disease Market?

Leading companies within the deep brain stimulation in Parkinson’s disease market are prioritizing the creation of advanced products, including miniaturized rechargeable implantable pulse generators and integrated remote programming platforms, to improve patient comfort and expand access to treatment. This involves designing these battery-powered neurostimulation devices in significantly smaller, thinner form factors, enabling less invasive implantation while consistently delivering therapeutic electrical pulses over extended durations. For example, in January 2024, Abbott Laboratories, a US-based multinational medical devices and healthcare company, introduced its Liberta RC DBS system. This platform is a compact, rechargeable deep brain stimulation solution featuring remote programming capabilities, specifically engineered for individuals experiencing movement disorders such as Parkinson’s disease and essential tremor. The solution additionally offers the longest recharge interval of any FDA-approved DBS system, requiring only 10 recharge sessions a year for most people, and incorporates the NeuroSphere Virtual Clinic to facilitate patient-doctor communication and allow for treatment adjustments from the convenience of their homes.

Who Are The Companies Participating In The Deep Brain Stimulation In Parkinson`s Disease Market?

Major companies operating in the deep brain stimulation in parkinson`s disease market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Mayo Foundation for Medical Education and Research, Cleveland Clinic, Renishaw plc, Neuralink Corp., NeuroPace Inc., PINS Medical Co. Ltd., Neurosoft Ltd., BrainsWay Ltd., Medscape, Inomed Medizintechnik GmbH, SceneRay Corporation Ltd., Neuroelectrics Barcelona S.L., Soterix Medical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, NeuroSigma Inc., BrainGate Company Inc.

Get The Full Deep Brain Stimulation In Parkinson`s Disease Market Report:

https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-in-parkinsons-disease-market-report

Which Region Holds The Highest Market Share In The Deep Brain Stimulation In Parkinson`s Disease Market?

North America was the largest region in the deep brain stimulation in parkinson’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation in parkinson`s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Deep Brain Stimulation In Parkinson`s Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=30568&type=smp

Browse Through More Reports Similar to the Global Deep Brain Stimulation In Parkinson`s Disease Market 2026, By The Business Research Company

Deep Brain Stimulation Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-systems-global-market-report

Deep Brain Stimulation Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-device-global-market-report

spinal cord stimulation global market report

https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795